Cleared Traditional

K062127 - MEDIC4ALL TELEMEDICINE SYSTEM, MODEL VMS-01 (NIBP)

K062127 is an FDA 510(k) clearance for MEDIC4ALL TELEMEDICINE SYSTEM, manufactured by Medic4all (Israel) , Ltd.. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K062127 · Medic4all (Israel) , Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2006
Decision
106d
Days
Class 2
Risk

K062127 is an FDA 510(k) clearance for the MEDIC4ALL TELEMEDICINE SYSTEM, MODEL VMS-01 (NIBP). Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Medic4all (Israel) , Ltd. (Washington, US). The FDA issued a Cleared decision on November 8, 2006 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K062127

510(k) Number K062127 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2006
Decision Date November 08, 2006
Days to Decision 106 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 125d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 189
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K062127.
MODIFICATION TO HEALTH BUDDY APPLIANCE
K063612 · Health Hero Network, Inc. · Dec 2006
PATIENT DATA HANDLER & DEVICES (PDH&D)
K063484 · Intermed Advisors, Inc. · Dec 2006
TELEMEDICINE SYSTEM MODEL VMS-01
K062662 · Medic4all (Israel) , Ltd. · Nov 2006
CONFIDANT 2.0
K062215 · Confidant, Inc. · Oct 2006
DLM112 DAYLINK MONITOR
K062304 · Rtx Healthcare A/S · Sep 2006
MEDIC4ALL TELEMEDICINE SYSTEM VMS-01
K061502 · Medic4all (Israel) , Ltd. · Sep 2006
K062127 · MEDIC4ALL TELEMEDICINE SYSTEM, MODEL VMS-01 (NIBP)
Download PDF FDA Summary Medic4all (Israel) , …